Faes Farma SA
Research Faes Farma SA (FAE) on Bullrun: valuation model: 19.4% undervalued, market cap EUR 1.44B, P/E 17.6, dividend yield 3.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFAE
- ExchangeMC
- CountrySpain
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Valuation signal19.4% undervalued
- Market capEUR 1.44B
- P/E17.6
- Dividend yield3.9%
- Financial periodFY2025
- RevenueEUR 626.99M
- Revenue growth22.9%
- Net incomeEUR 79.63M
- Free cash flowEUR 62.39M
- Gross margin63.8%
Valuation Snapshot
Bullrun's latest valuation model marks Faes Farma SA as 19.4% undervalued; latest market cap is EUR 1.44B; P/E is 17.6; dividend yield is 3.9%.
About Faes Farma SA
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments.
Frequently asked questions
Is Faes Farma SA overvalued or undervalued?
Bullrun's valuation model currently marks Faes Farma SA as 19.4% undervalued.
What is Faes Farma SA's market cap?
Faes Farma SA's market capitalization is EUR 1.44B.
What is Faes Farma SA's P/E ratio?
Faes Farma SA's price-to-earnings (P/E) ratio is 17.6.
Does Faes Farma SA pay a dividend?
Faes Farma SA has a dividend yield of 3.9%.
What does Faes Farma SA do?
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments.